Arbutus Biopharma Corporation (FRA:I9DN)
3.906
-0.154 (-3.79%)
At close: Jan 9, 2026
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of €763.88 million as of January 9, 2026. Its market cap has increased by 31.39% in one year.
Market Cap
763.88M
Enterprise Value
687.28M
Revenue
12.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.91
Market Cap Chart
Since November 15, 2010, Arbutus Biopharma's market cap has increased from 53.50M to 763.88M, an increase of 1,327.78%. That is a compound annual growth rate of 19.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 763.88M | -3.05% |
| Dec 31, 2025 | 787.89M | 31.64% |
| Dec 31, 2024 | 598.51M | 57.80% |
| Dec 29, 2023 | 379.28M | 11.19% |
| Dec 30, 2022 | 341.13M | -26.27% |
| Dec 31, 2021 | 462.69M | 87.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |